Columbia University DKV | New York Academy of Sciences | Mailman School of Public Health | NIAID
Home Feedback | About | print Print | Help
Search
Speakers
Latest Headlines
Executive Summary
Topics and Speakers
Coronavirus Biology and PathogenesisRegistration Required
On the Front LinesRegistration Required
Clinical Spectrum of SARS Infection
Clinical Experience in Toronto
SARS: An Update from China
Panel 2 Discussion
Approaches to Vaccines and Drug DevelopmentRegistration Required
Future Perspectives on Emerging InfectionsRegistration Required
References and Resources
pdf Conference TranscriptRegistration Required
pdf Conference HighlightsRegistration Required
SARS in the Context of Emerging Infectious Threats SARS in the Context of Emerging Infectious Threats
On the Front Lines
SARS: An Update from China

Chen Zhu, Shanghai Second Medical University, People's Republic of China.
Delivered by Dr. Scott Hammer.
Play Video Read Transcript
View SlidesView Slides | Biography | Contact

Highlights

Impact on China
• China is hardest hit by SARS, with 5000 cases, almost half in Beijing.
• China has devoted a science and technology task group to work on SARS epidemiology, diagnostics, treatment, disease mechanism, biosafety and infection control, and education.

Task-Force Activities
• Modeling and predicting the trajectory of the epidemic.
• Screening possible drugs and vaccines, including some from traditional Chinese medicines.
• Screening humanized monoclonal antibodies.
• Looking into antisense oligonucleotides or RNA interference.
• Determining host susceptibility issues.
• Building collaborative scientific relationships and sharing resources.

Previous | Next
Columbia University Digital Knowledge Ventures New York Academy of Sciences Columbia University Mailman School of Public Health National Institute of Allergy and Infectious Diseases United States Department of Health & Human Services
© 2003 Columbia University | Privacy Policy.
This Web site is being provided to you for your own use.
Any copying or distribution of this Web site is prohibited.